Radtreo Injection

Name: Radtreo Injection
Brand: Shree Maruti Pharma
Price: 385 INR
Availability: InStock

Price 385 INR/ Piece

Get a Price/Quote

MOQ : 100 Pieces

Radtreo Injection Specification

Origin of Medicine
India

Life Span
As per expiry on vial

Brand Name
Radtreo

Salt Composition
PSMA-11 peptide

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Lyophilized powder for solution

Indication
PET imaging of prostate-specific membrane antigen (PSMA)-positive lesions

Packaging Type
Vial in a box

Drug Type
Radiopharmaceutical

Ingredients
Kit for preparation of Ga-68 PSMA-11 injection

Physical Form
Injection

Function
Diagnostic radiopharmaceutical

Recommended For
Diagnosis of prostate cancer

Dosage
As prescribed by physician

Dosage Guidelines
For intravenous use after radiolabeling

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C. Protect from light.

Manufactured By
Jubilant Radiopharma

Radiotracer
Gallium-68 labeled PSMA-11

Molecular Target
Prostate-Specific Membrane Antigen (PSMA)

Intended Use
PET/CT imaging

Application
Oncology, Nuclear Medicine

Regulatory Status
Prescription only, Registered medical product

Shelf Life After Reconstitution
Use immediately after preparation

Reconstitution Instructions
Requires radiolabeling with Ga-68 prior to administration

Administration Route
Intravenous injection

Container Material
Glass vial

Prescription/Non Prescription
Prescription

Radtreo Injection Trade Information

Minimum Order Quantity
100 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Radtreo Injection

Unlock wondrous diagnostic precision with Radtreo Injection, featuring the exclusive Gallium-68 labeled PSMA-11 radiotracer. Manufactured by Jubilant Radiopharma, this prescription-only marvel is perfect for oncology clinics seeking advanced PET/CT imaging in prostate cancer diagnosis. Its glorious efficiency targets Prostate-Specific Membrane Antigen (PSMA), delivering rapid results and offering substantial savings in clinical workflows. Packed as a lyophilized powder in a glass vial, Radtreo guarantees reliability, with each box containing one ready-to-radiolabel kit-an exceptional bargain for medical professionals seeking dependable results.

Exceptional Use in Modern Clinical Imaging

Radtreo Injection is primarily used in oncology and nuclear medicine departments for the diagnosis of prostate cancer. Its specific application in PET/CT imaging enables clinicians to identify PSMA-positive lesions with great accuracy. Used for adult patients, the injection must be radiolabeled with Ga-68 and administered intravenously as prescribed. Its wondrous precision and targeted imaging make it an invaluable tool for hospitals, imaging centers, and specialty diagnostics hubs.

Export Markets, Packaging, and Sample Availability

Radtreo enjoys a strong domestic market and presence in international regions, with availability to distributors, suppliers, and traders across India. Packaged securely, each purchase order contains one glass vial in a box, ensuring product integrity. Samples may be offered upon request, making it easy for new clients to evaluate before committing. This product is designed for seamless procurement on both domestic and export levels, meeting the exacting standards required for medical distribution.

FAQ's of Radtreo Injection:

Q: How should Radtreo Injection be stored before and after reconstitution?

A: Radtreo Injection must be stored below 25C and protected from light. After radiolabeling and reconstitution, it should be used immediately and not stored for later use.

Q: What is the main benefit of using Gallium-68 labeled PSMA-11 in Radtreo?

A: The key benefit is its high specificity for PSMA, allowing for accurate detection of prostate cancer lesions during PET/CT imaging, which supports enhanced diagnostic confidence.

Q: When should Radtreo Injection be administered to a patient?

A: Radtreo should be administered intravenously immediately after being radiolabeled with Gallium-68, strictly as prescribed by a qualified healthcare specialist.

Q: Where can Radtreo Injection be supplied or distributed?

A: Radtreo Injection is distributed to authorized medical facilities, hospitals, and nuclear medicine centers in India and selected international markets via registered distributors and suppliers.

Q: What is the process for preparing Radtreo Injection for patient use?

A: The kit includes PSMA-11 peptide lyophilized powder that must be radiolabeled with Gallium-68 prior to intravenous administration. Follow all reconstitution instructions provided in the packaging for safe and effective use.

Tell us about your requirement